For most healthy individuals, clinical assessment and subjective response monitoring provide adequate oversight without laboratory testing requirements
Does semaglutide cause gallstones
Molecular effects of genistein on estrogen receptor mediated pathways
Perfect for planning, doodling, and more
1 This study is the first to evaluate the association between GLP-1 agonist use and key clinical outcomes, including anemia, transfusion, hospitalization, and mortality, in a large-scale analysis of patients with celiac disease. Investigators sourced data for the present study from TriNetX and identified patients with celiac disease using ICD-10 codes, stratifying them according to documented exposure to GLP-1 agonists, including semaglutide, dulaglutide, liraglutide, or exenatide